Approval Date: Sep 2022
Indicated for the treatment of hypertension, to lower blood pressure
Approval Date: Sep 2022
Indicated for the treatment of HIV-1 infection
Approval Date: Sep 2022
Indicated for the treatment of moderate-to-severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy
Approval Date: Aug 2022
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
Approval Date: Aug 2022
Indicated for the adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)
Approval Date: Aug 2022
Indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome
Approval Date: Aug 2022
For the treatment of major depressive disorder, this antidepressant is notable for producing antidepressant results within one week
Approval Date: Jul 2022
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
Approval Date: Jul 2022
Indicated for the treatment of hypertension to lower blood pressure
Approval Date: Jul 2022
An NSAID used for the relief of mild to moderate pain or relief in the signs and symptoms of rheumatoid arthritis or osteoarthritis